Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Johnson & Johnson revealed that the U.S. Food and Drug Administration has granted approval for the use of RYBREVANT® in combination with chemotherapy as a first-line treatment for patients diagnosed...
Merck, has announced that the U.S. Food and Drug Administration (FDA) has granted approval for sotatercept-csrk under the brand name WINREVAIR™. ...
Researchers at the College of Medicine are pioneering a new approach to combat glioblastoma, an aggressive and currently incurable form of brain cancer. Despite existing treatments such as surgery, radiation, and chemotherapy, patients typically face a grim...
Biogen recently announced a groundbreaking development: the European Commission has officially authorized SKYCLARYS® for treating Friedreich’s ataxia in adults and adolescents aged 16 years and older. This marks a significant step forward as...
Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3 targeting ADC, known as 7MW3711. This ADC,...
Iovance Biotherapeutics has gained approval from the U.S. Food and Drug Administration for AMTAGVI™ suspension for intravenous infusion. This treatment is tailored for adults facing unresectable or metastatic melanoma...
Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3...
Bayer made a recent announcement stating that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for BAY 2927088. This designation is for the treatment of adult patients...
Neurologists at the Indiana University School of Medicine have commenced administering a pioneering gene-based therapy for individuals afflicted with a rare variant of amyotrophic lateral sclerosis...
Researchers at The University of Texas at El Paso have identified a groundbreaking pharmaceutical compound that shows promise in eliminating leukemia and lymphoma cancer cells, offering potential advancements in treatment options...
